From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

BARDA Awards Medical Countermeasure Clinical Studies Network Contracts

by Global Biodefense Staff
March 26, 2014

The Biomedical Advanced Research and Development Authority (BARDA) has recently awarded five indefinite delivery, indefinite quantity (IDIQ) contracts in support of the Medical Countermeasure Clinical Studies Network.

The goal of the network is to generate clinical trial data that will evaluate medical countermeasures, such as vaccines, therapeutics, diagnostics and medical devices. 

The awardees will provide a full range of services including statistical expertise and project management, study design and protocol development, data collection, and data analysis and reporting.  The two-year contracts, which includes three one-year options, each have a ceiling of $100 million and a minimum order guarantee of $400,000.

The following organizations were awarded the IDIQ contracts:

  • Clinical Research Management, Inc.
  • The EMMES Corporation
  • PPD Development
  • Rho Federal Systems Division, Inc.
  • Technical Resources International, Inc.

Studies performed by this network will clinically evaluate Chemical, Biological, Radiological, Nuclear (CBRN), pandemic influenza and emerging infectious disease medical countermeasures. These studies may be Phase 1, 2, 3, or 4 or combinations of such.

Source: RFP-13-100-SOL-00008 (FBO.gov)

From Our Partners
Tags: ASPRAwardsBARDAHHSPandemicVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC